Vetoquinol: net income down 24% by 2022
The animal health laboratory reported sales of €539.8 million for 2022, up 3.6% (of which +4.5% for Essentials and +9.1% for the companion animals segment) and down 0.8% at constant exchange rates.
Confident in its ability to deploy its 'Ambition 2026' strategic plan and pursue its sustainable, profitable development, Vetoquinol will propose a dividend of €0.80 per share at the AGM on May 25.
Copyright (c) 2023 CercleFinance.com. All rights reserved.
Go to the original article.
Contact us to request a correction